Fresenius Kabi USA, LLC

Form 483 issued March 6, 2015 · Grand Island, New York

Inspection
Mar 2 – Mar 6, 2015
Investigator
James D. Bridges
Observations
2
Pages
1
FEI number
3001833549

In short: On March 6, 2015, FDA issued a Form 483 with 2 observations to Fresenius Kabi USA, LLC in Grand Island, New York (FEI 3001833549) after an inspection that ran Mar 2 – Mar 6, 2015. The investigator was James D. Bridges. Most observations concern production and facilities & equipment; the most-cited regulation is 21 CFR 211.103 (calculation of yield).

At a glance

Production and facilities & equipment account for 2 of 2 observations.

Production1
Facilities & equipment1

Most cited: 21 CFR 211.103 (1×) · 211.42 (1×)

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    Actual yield and percentages of theoretical yield are not determined at the conclusion of each appropriate…

  2. 02

    Aseptic processing areas are deficient regarding the system…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Fresenius Kabi USA, LLC?

FDA listed 2 observations on this Form 483, mostly about production and facilities & equipment. The most-cited regulation is 21 CFR 211.103 (calculation of yield). The opening words of each observation are shown on this page.

Who inspected Fresenius Kabi USA, LLC?

James D. Bridges is named on this Form 483, for the inspection of Mar 2 – Mar 6, 2015. Each investigator has a profile showing what they cite most.

When was Fresenius Kabi USA, LLC inspected by FDA?

The inspection ran Mar 2 – Mar 6, 2015, and the Form 483 is dated March 6, 2015.

How do I get the full Form 483 for Fresenius Kabi USA, LLC?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free